Work

Osimertinib Western and Asian clinical pharmacokinetics in patients and healthy volunteers: implications for formulation, dose, and dosing frequency in pivotal clinical studies

Year: 2016

Type: article

Source: Cancer Chemotherapy and Pharmacology

DOI: 10.1007/s00280-016-2992-z

Authors: David Planchard, Kathryn H. Brown, Dong-Wan Kim, Sang-We Kim, Yuichiro Ohe, Enriqueta Felip, Philip Leese, Mireille Cantarini, Karthick Vishwanathan, Pasi A. Jänne, Malcolm Ranson, Paul A. Dickinson

Institutions: Institut Gustave Roussy, AstraZeneca (United Kingdom), Seoul National University, Seoul National University Hospital, Asan Medical Center, National Cancer Center Hospital, Vall d'Hebron Hospital Universitari, IQVIA (United States), AstraZeneca (United States), Dana-Farber Cancer Institute, University of Manchester, The Christie Hospital

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: AstraZeneca

OpenAlex ID: W2280175247

FWCI: 14.87

Cites: 19

Cited by: 149

Related to: 10